Abstract:109Tissue-engineered scaffolds are more commonly used to construct three-dimensional (3D) tumor models for in vitro studies when compared to the conventional two-dimensional (2D) cell culture because the microenvironments provided by the 3D tumor models closely resemble the in vivo system and could achieve higher success rate when the scaffolds are translated for use in pre-clinical animal model. Physical properties, heterogeneity, and cell behaviors of the model could be regulated to simulate different tumors by changing the components and concentrations of materials. In this study, a novel 3D breast tumor model was fabricated by bioprinting using a bioink that consists of porcine liver-derived decellularized extracellular matrix (dECM) with different concentrations of gelatin and sodium alginate. Primary cells were removed while extracellular matrix components of porcine liver were preserved. The rheological properties of biomimetic bioinks and the physical properties of hybrid scaffolds were investigated, and we found that the addition of gelatin increased hydrophilia and viscoelasticity, while the addition of alginate increased mechanical properties and porosity. The swelling ratio, compression modulus, and porosity could reach 835.43 ± 130.61%, 9.64 ± 0.41 kPa, and 76.62 ± 4.43%, respectively. L929 cells and the mouse breast tumor cells 4T1 were subsequently inoculated to evaluate biocompatibility of the scaffolds and to form the 3D models. The results showed that all scaffolds exhibited good biocompatibility, and the average diameter of tumor spheres could reach 148.52 ± 8.02 μm on 7 d. These findings suggest that the 3D breast tumor model could serve as an effective platform for anticancer drug screening and cancer research in vitro.

Bioprinting of Glioma Stem Cells Improves Their Endotheliogenic Potential.

Vascularization Ability of Glioma Stem Cells in Different Three-Dimensional Microenvironments.

3dbioprinted Glioma Microenvironment For Glioma Vascularization

3D bioprinted glioma cell-laden scaffolds enriching glioma stem cells via epithelial-mesenchymal transition.

3D Bioprinted Glioma Stem Cells for Brain Tumor Model and Applications of Drug Susceptibility.

3D Bioprinted Hyaluronic Acid-Based Cell-Laden Scaffold for Brain Microenvironment Simulation

Biomimetic Three-Dimensional Glioma Model Printed in Vitro for the Studies of Glioma Cells and Neurons Interactions.

Coaxially Bioprinted Cell-Laden Tubular-Like Structure for Studying Glioma Angiogenesis

A 3D Bioprinted Human Neurovascular Unit Model of Glioblastoma Tumor Growth (Adv. Healthcare Mater. 15/2024)

Coaxial Extrusion Bioprinted Shell-Core Hydrogel Microfibers Mimic Glioma Microenvironment and Enhance the Drug Resistance of Cancer Cells

Comprehensive insight into 3D bioprinting technology for brain tumor modeling

Fusion between Glioma Stem Cells and Mesenchymal Stem Cells Promotes Malignant Progression in 3D-Bioprinted Models

Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma

Coaxial Bioprinted Microfibers with Mesenchymal Stem Cells for Glioma Microenvironment Simulation

Cell-modified Bioprinted Microspheres for Vascular Regeneration

A 3D‐Bioprinted Vascularized Glioblastoma‐on‐a‐Chip for Studying the Impact of Simulated Microgravity as a Novel Pre‐Clinical Approach in Brain Tumor Therapy

A 3D bioprinted tumor model fabricated with gelatin/sodium alginate/decellularized extracellular matrix bioink

Glioblastoma Stem Cell Differentiation into Endothelial Cells Evidenced Through Live-Cell Imaging.

A 3D Bioprinted Human Neurovascular Unit Model of Glioblastoma Tumor Growth

Recapitulating Glioma Stem Cell Niches Using 3D Spheroid Models for Glioblastoma Research

Enrichment of Glioma Stem Cell-Like Cells on 3D Porous Scaffolds Composed of Different Extracellular Matrix